David H. Spencer

12.2k citations

57 papers · 3.8k indexed · 1 hit paper · h-index 25

Co-authors: Maynard V. Olson Rajinder Kaul Christopher K. Raymond Eric Haugen Chunrong Liu Ruth Levy Michael A. Jacobs Stephen A. Ernst
Topics: Acute Myeloid Leukemia Research (19 papers)Cancer Genomics and Diagnostics (15 papers)Epigenetics and DNA Methylation (11 papers)
Cited by: Molecular Medicine Hematology Endocrinology
Journals: Cell Proceedings of the National Academy of Sciences JAMA
Partner nations: United States Canada United Kingdom

In The Last Decade

David H. Spencer

56 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comprehensive transposon mutant library of Pseudomonas aeruginosa

2003 932 citations David H. Spencer, Maynard V. Olson et al. profile →

Peers

Countries citing papers authored by David H. Spencer

Since Specialization

Citations

This map shows the geographic impact of David H. Spencer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David H. Spencer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David H. Spencer more than expected).

Fields of papers citing papers by David H. Spencer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David H. Spencer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David H. Spencer. The network helps show where David H. Spencer may publish in the future.

Co-authorship network of co-authors of David H. Spencer

This figure shows the co-authorship network connecting the top 25 collaborators of David H. Spencer. A scholar is included among the top collaborators of David H. Spencer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David H. Spencer. David H. Spencer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Innovations in Short-Read Sequencing Technologies and Their Applications to Clinical Genomics 2025 ·Clinical Chemistry ·Katarzyna Polonis,Joseph H. Blommel,Andrew Hughes,David H. Spencer,(unknown),Molly C. Schroeder	5
2	A fully next-generation sequencing-based method of classifying molecular sub-types of endometrial cancer retains prognostic value and expands biomarker targets 2025 ·International Journal of Gynecological Cancer ·Mark C. Valentine,Amanda Wong,Ling Chen,Feiyu Du,Andrew Hughes,David H. Spencer,Eric J. Duncavage,Lulu Sun	0
3	Missense Mutations in Myc Box I Influence Nucleocytoplasmic Transport to Promote Leukemogenesis 2024 ·Clinical Cancer Research ·(unknown),(unknown),(unknown),Marianna B. Ruzinova,Ashutosh Kumar,(unknown),Ryan B. Day,Petra Erdmann-Gilmore,Yiling Mi,Robert W. Sprung,(unknown),R. Reid Townsend,David H. Spencer,Stephen M. Sykes,Francesca Ferraro	2
4	Genomic landscape of TP53-mutated myeloid malignancies 2023 ·Blood Advances ·Haley Abel,Karolyn A. Oetjen,Christopher A. Miller,Sai Mukund Ramakrishnan,Ryan B. Day,Nichole Helton,Catrina C. Fronick,Robert S. Fulton,Sharon E. Heath,(unknown),Sridhar Nonavinkere Srivatsan,Eric J. Duncavage,Molly C. Schroeder,Jacqueline E. Payton,David H. Spencer,Matthew J. Walter,Peter Westervelt,John F. DiPersio,Timothy J. Ley,Daniel C. Link	15
5	KDM6B protects T-ALL cells from NOTCH1-induced oncogenic stress 2023 ·Leukemia ·(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Christine Zhang,Wentao Han,Andrew L. Young,(unknown),Kai Ge,Eunice S. Wang,Andrew P. Weng,Amanda F. Cashen,David H. Spencer,Grant A. Challen	9
6	Clinical whole‐genome sequencing in cancer diagnosis 2022 ·Human Mutation ·Ying‐Chen Claire Hou,Julie Neidich,Eric J. Duncavage,David H. Spencer,Molly C. Schroeder	13
7	Failure to Detect Mutations in U2AF1 due to Changes in the GRCh38 Reference Sequence 2022 ·Journal of Molecular Diagnostics ·Christopher A. Miller,Jason Walker,(unknown),(unknown),Robert S. Fulton,Jeffrey S. Painter,Mikkael A. Sekeres,Timothy J. Ley,David H. Spencer,Johannes B. Goll,Matthew J. Walter	14
8	Heterozygous variants of CLPB are a cause of severe congenital neutropenia 2021 ·Blood ·Julia T. Warren,Ryan R. Cupo,(unknown),David H. Spencer,Adam E. Locke,Vahagn Makaryan,Audrey Anna Bolyard,Merideth L. Kelley,Natalie L. Kingston,James Shorter,Christine Bellanné‐Chantelot,Jean Donadieu,David C. Dale,Daniel C. Link	24
9	Focal disruption of DNA methylation dynamics at enhancers in IDH-mutant AML cells 2021 ·Leukemia ·(unknown),Nichole Helton,Sharon E. Heath,Robert S. Fulton,Jacqueline E. Payton,John S. Welch,Matthew J. Walter,Peter Westervelt,John F. DiPersio,Daniel C. Link,Christopher A. Miller,Timothy J. Ley,David H. Spencer	19
10	Tumor suppressor function of <I>WT1</I> in acute promyelocytic leukemia 2021 ·Haematologica ·Matthew Christopher,(unknown),(unknown),(unknown),(unknown),Margery Gang,Andrew J. Menssen,David H. Spencer,Eric J. Duncavage,Shamika Ketkar,Lukas D. Wartman,Sai Mukund Ramakrishnan,Christopher A. Miller,Timothy J. Ley	6
11	Contribution of CTCF binding to transcriptional activity at the HOXA locus in NPM1-mutant AML cells 2020 ·Leukemia ·Reza Ghasemi,(unknown),(unknown),David H. Spencer	18
12	CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression 2017 ·Cell ·David H. Spencer,David A. Russler‐Germain,Shamika Ketkar,Nichole Helton,Tamara Lamprecht,Robert S. Fulton,Catrina C. Fronick,Michelle D. O’Laughlin,Sharon E. Heath,Marwan Shinawi,Peter Westervelt,Jacqueline E. Payton,Lukas D. Wartman,John S. Welch,Richard K. Wilson,Matthew J. Walter,Daniel C. Link,John F. DiPersio,Timothy J. Ley	149
13	mlo ‐based powdery mildew resistance in hexaploid bread wheat generated by a non‐transgenic TILLING approach 2016 ·Plant Biotechnology Journal ·Johanna Acevedo‐Garcia,David H. Spencer,Hannah Thieron,Anja Reinstädler,K. E. Hammond‐Kosack,Andrew L. Phillips,Ralph Panstruga	134
14	The R882H DNMT3A Mutation Associated with AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers 2014 ·Cancer Cell ·David A. Russler‐Germain,David H. Spencer,Margaret A. Young,Tamara Lamprecht,Chris Miller,Robert S. Fulton,Matthew R. Meyer,Petra Erdmann-Gilmore,R. Reid Townsend,Richard K. Wilson,T J Ley	316
15	Functional Heterogeneity of Genetically Defined Subclones in Acute Myeloid Leukemia 2014 ·Cancer Cell ·Jeffery M. Klco,David H. Spencer,Chris Miller,Malachi Griffith,Tamara Lamprecht,Michelle D. O’Laughlin,Catrina C. Fronick,Vincent Magrini,Ryan Demeter,Robert S. Fulton,William Eades,Daniel C. Link,Timothy A. Graubert,Matthew J. Walter,Elaine R. Mardis,John F. DiPersio,Richard K. Wilson,T J Ley	264
16	Comparison of Clinical Targeted Next-Generation Sequence Data from Formalin-Fixed and Fresh-Frozen Tissue Specimens 2013 ·Journal of Molecular Diagnostics ·David H. Spencer,Jennifer K. Sehn,Haley Abel,Mark A. Watson,John D. Pfeifer,Eric J. Duncavage	123
17	Performance of Common Analysis Methods for Detecting Low-Frequency Single Nucleotide Variants in Targeted Next-Generation Sequence Data 2013 ·Journal of Molecular Diagnostics ·David H. Spencer,Manoj Tyagi,Francesco Vallania,Andrew J. Bredemeyer,John D. Pfeifer,Robi D. Mitra,Eric J. Duncavage	84
18	Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients 2007 ·Molecular Microbiology ·David A. D’Argenio,Manhong Wu,Lucas R. Hoffman,Hemantha D. Kulasekara,Éric Déziel,Eric E. Smith,(unknown),Robert K. Ernst,Theodore J. Larson Freeman,David H. Spencer,M. Brittnacher,Hillary S. Hayden,(unknown),Mikkel Klausen,David R. Goodlett,Jane L. Burns,Bonnie W. Ramsey,Samuel I. Miller	278
19	Detecting Disease-Causing Mutations in the Human Genome by Haplotype Matching 2006 ·The American Journal of Human Genetics ·David H. Spencer,Kerry L. Bubb,Maynard V. Olson	3
20	A field study of use of synchronous computer-mediated communication in asynchronous learning networks 2002 ·David H. Spencer,Starr Roxanne Hiltz	6

About David H. Spencer

David H. Spencer is a scholar working on Hematology, Cancer Research and Aging, having authored 57 papers that have together received 3.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (19 papers), Cancer Genomics and Diagnostics (15 papers) and Epigenetics and DNA Methylation (11 papers). The work is most often cited by research in Molecular Medicine (553 citations), Hematology (783 citations) and Endocrinology (284 citations). David H. Spencer has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Maynard V. Olson, Rajinder Kaul, Christopher K. Raymond, Eric Haugen, Chunrong Liu, Ruth Levy, Michael A. Jacobs, Stephen A. Ernst, Iyarit Thaipisuttikul and Colin Manoil. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact